SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

11 Nov 2025 Evaluate
The company witnessed a 21.99% growth in the revenue at Rs. 423.49 millions for the quarter ended September 2025 as compared to Rs. 347.16 millions during the year-ago period.Good  Net Profit growth of 35.00% reported above the corresponding previous quarter figure of Rs. 105.67 millions to Rs. 142.65 millioins.Operating Profit saw a handsome growth to 217.60 millions from 157.10 millions in the quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 423.49 347.16 21.99 782.22 735.43 6.36 1508.00 1698.22 -11.20
Other Income 8.16 3.19 155.80 10.90 8.43 29.30 24.32 43.66 -44.30
PBIDT 217.60 157.10 38.51 359.56 347.85 3.37 712.76 831.00 -14.23
Interest 0.40 0.82 -51.22 0.82 1.48 -44.59 3.64 2.29 58.95
PBDT 217.20 156.28 38.98 358.74 346.37 3.57 709.12 828.71 -14.43
Depreciation 29.59 14.36 106.06 49.93 25.84 93.23 53.75 35.36 52.01
PBT 187.61 141.92 32.19 308.81 320.53 -3.66 655.37 793.35 -17.39
TAX 44.96 36.25 24.03 75.54 82.49 -8.43 167.66 201.71 -16.88
Deferred Tax 14.13 0.08 17562.50 20.05 0.61 3186.89 2.80 3.75 -25.33
PAT 142.65 105.67 35.00 233.27 238.04 -2.00 487.71 591.64 -17.57
Equity 108.97 108.97 0.00 108.97 108.97 0.00 108.97 72.64 50.01
PBIDTM(%) 51.38 45.25 13.55 45.97 47.30 -2.82 47.27 48.93 -3.41

Guj. Themis Biosyn Share Price

319.45 15.45 (5.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×